Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - tadalafil 5 mg - film-coated tablet - tadalafil

Իսրայել - անգլերեն - Ministry of Health

teva pharmaceutical industries ltd, israel - tadalafil - tablets - tadalafil 10 mg - tadalafil - for the treatment of erectile dysfunction in adult men.

Կանադա - անգլերեն - Health Canada

teva canada limited - tadalafil - tablet - 2.5mg - tadalafil 2.5mg - phosphodiesterase type 5 inhibitors

Կանադա - անգլերեն - Health Canada

teva canada limited - tadalafil - tablet - 5mg - tadalafil 5mg - phosphodiesterase type 5 inhibitors

Կանադա - անգլերեն - Health Canada

teva canada limited - tadalafil - tablet - 10mg - tadalafil 10mg - phosphodiesterase type 5 inhibitors

Կանադա - անգլերեն - Health Canada

teva canada limited - tadalafil - tablet - 20mg - tadalafil 20mg - phosphodiesterase type 5 inhibitors

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

avkare - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [ see clinical pharmacology ( 12.2) ]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (or a

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [ see clinical pharmacology ( 12.2) ]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (or a

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

avkare - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [ see clinical pharmacology ( 12.2) ]. tadalafil tablets are contraindicated in p

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

proficient rx lp - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2) ]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (or adcirca® ). hypers